Page last updated: 2024-09-02

3,5-dihydroxyphenylglycine and Brain Diseases

3,5-dihydroxyphenylglycine has been researched along with Brain Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gruol, DL; Nelson, TE; Netzeband, JG	1

Other Studies

1 other study(ies) available for 3,5-dihydroxyphenylglycine and Brain Diseases

Article	Year
Chronic interleukin-6 exposure alters metabotropic glutamate receptor-activated calcium signalling in cerebellar Purkinje neurons. The European journal of neuroscience, 2004, Volume: 20, Issue:9 Topics: Adenosine Triphosphatases; Animals; Brain Diseases; Calcium; Calcium Channel Blockers; Calcium Signaling; Cells, Cultured; Drug Administration Schedule; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Glycine; Interleukin-6; Intracellular Fluid; Membrane Potentials; Potassium; Purkinje Cells; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Resorcinols; Ryanodine Receptor Calcium Release Channel; Up-Regulation	2004

Article

Year

Chronic interleukin-6 exposure alters metabotropic glutamate receptor-activated calcium signalling in cerebellar Purkinje neurons.

The European journal of neuroscience, 2004, Volume: 20, Issue:9

Topics: Adenosine Triphosphatases; Animals; Brain Diseases; Calcium; Calcium Channel Blockers; Calcium Signaling; Cells, Cultured; Drug Administration Schedule; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Glycine; Interleukin-6; Intracellular Fluid; Membrane Potentials; Potassium; Purkinje Cells; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Resorcinols; Ryanodine Receptor Calcium Release Channel; Up-Regulation

2004